
Specifications | |
Business section |
Specifications | |
Suggested Link Details/Purchase | |
Content | ®Morningstar Stock Data SheetPricing data thru Feb. 01, 2012 Rating updated as of Feb. 01, 2012Pricing data thru Feb. 01, 2012 Rating updated as of Feb. 01, 2012Fiscal year-end: December AspenBio Pharma, Inc.APPY Sales USD MilMkt Cap USD MilIndustrySector 07Diagnostics & Research Healthcare TMMorningstar RatingLast PriceFair ValueUncertaintyEconomic MoatStewardship Grade —0.84. per share prices in USD 2002200320042005200620072008200920102011YTD 1.1 4.0 19.0 49.0 29.0 199.0 23.255.359.002.155.952.5514.754.7575.8013.9045.3517.9038.905.2224.901.504.850.951.000.80 Annual Price High Low Recent Splits Price Volatility Monthly High/Low Rel Strength to S&P 500 52 week High/Low 4.85 - 0.80 10 Year High/Low 75.80 - 0.80 Bear-Market Rank 0 (10=worst) Trading Volume Hundred Stock Performance 1:5 AspenBio Pharma is a healthcare product development company. The company has products in multiple stages of development dealing with human diagnostic and animal healthcare related issues. These include the company’s headliner known as AppyScore, which acts as a test for acute appendicitis. There are also several other drugs being developed and intended for use in animal production. 1585 South Perry Street Castle Rock, CO 80104 Phone: 1 303 794-2000Website: http://www.aspenbioinc.com Growth RatesCompound Annual Grade: F1 Yr3 Yr5 Yr10 Yr Revenue %-26.7-24.2-15.5. Operating Income %. Earnings/Share %. Dividends %. Book Value/Share %-18.1-33.212.8. Stock Total Return %-72.5-51.8-44.3. +/- Industry-79.7-63.4-45.2. +/- Market-73.8-68.8-42.5. Profitability Analysis Grade: FCurrent5 Yr AvgIndMkt Return on Equity %.2.822.4 Return on Assets %-79.2-49.71.39.5 Fixed Asset Turns0.10.25.07.5 Inventory Turns1.81.49.115.9 Revenue/Employee USD K7.418.6.1048.4 Gross Margin %55.630.146.138.3 Operating Margin %-4344.4-1800.68.916.6 Net Margin %.-1775.72.011.1 Free Cash Flow/Rev %.9.70.1 R&D/Rev %2218.59.1.9.8 * *3Yr Avg data is displayed in place of 5Yr Avg Financial Position Grade: D12-10 USD Mil09-11 USD Mil Cash92 Inventories00 Receivables00 Current Assets125 Fixed Assets33 Intangibles22 Total Assets1710 Payables11 Short-Term Debt00 Current Liabilities33 Long-Term Debt3. Total Liabilities66 Total Equity114 2001200220032004200520062007200820092010TTMFinancials Revenue USD Mil11111111100 Gross Margin %85.712.020.040.040.733.327.129.358.02.755.6 Oper Income USD Mil0-1-1-2-2-3-6-10-16-13-12 Operating Margin %17.9-124.0-198.5-221.3-220.9-258.8-758.8-1240.2-3110.0-3635.1-4344.4 Net Income USD Mil0-1-2-2-2-3-6-10-16-13-12 Earnings Per Share USD.-0.65-0.95-0.95-0.75-0.90-1.20-1.55-2.35-1.70-1.45 Dividends USD. Shares Mil.2223356788 Book Value Per Share USD.-0.090.410.771.234.702.871.711.400.450.45 Oper Cash Flow USD Mil000-1-2-3-12-6-11-11-9 Cap Spending USD Mil0-10000-1-1-1-10 Free Cash Flow USD Mil0-1-1-1-2-3-13-7-12-11-9 Valuation Analysis Current5 Yr AvgIndMkt Price/Earnings.97.114.4 Forward P/E.13.7 Price/Cash Flow.14.17.3 Price/Free Cash Flow.20.216.9 Dividend Yield %.0.22.0 Price/Book1.95.92.71.9 Price/Sales25.3.1.91.2 PEG Ratio.1.5 Total Return %.-40.953.9195.0195.6-29.2-71.8-65.3-67.8-13.4 +/- Market.-49.950.9181.4192.19.3-95.2-78.1-67.8-18.7 +/- Industry.-66.844.5183.6174.33.3-85.8-71.5-66.7-25.1 Dividend Yield %.0.0 Market Cap USD Mil.1081653246192652487 2001200220032004200520062007200820092010TTMProfitability Return on Assets %.-36.0-35.5-40.8-33.8-39.3-30.7-34.3-71.2-73.0-79.2 Return on Equity %.-90.8-40.1-43.1. Net Margin %8.9. Asset Turnover.0.220.130.160.140.140.040.030.020.020.02 Financial Leverage.11.9.5.62.92.01.21.41.51.52.8 200120022003200420052006200720082009201009-11Financial Health Working Capital USD Mil1-2.124251611102 Long-Term Debt USD Mil0144433333. Total Equity USD Mil100124271813114 Debt/Equity.2.08.3.981.520.770.110.150.210.230.68 2002200320042005200620072008200920102011TTMValuation Price/Earnings. P/E vs. Market. Price/Sales.15.68.815.643.5.114.964.129.225.3 Price/Book.7.96.512.09.310.85.12.12.21.9 Price/Cash Flow. Quarterly Results Revenue Rev Growth Earnings Per Share USD MilDec 10Mar 11Jun 11Sep 11 %Dec 10Mar 11Jun 11Sep 11 USDDec 10Mar 11Jun 11Sep 11 Most Recent Period0.10.10.10.0 Prior Year Period0.30.20.10.1 Most Recent Period-67.9-25.0-12.5-50.0 Prior Year Period133.360.0-11.114.3 Most Recent Period-0.37-0.35-0.35-0.38 Prior Year Period-0.75-0.50-0.45-0.40 Industry Peers by Market Cap Major Fund Holders Mkt Cap USD MilRev USD MilP/EROE% % of shares AspenBio Pharma, Inc70. Sun Pharma Advanced . Sun Pharma Advanced . . . . TTM data based on rolling quarterly data if available; otherwise most recent annual data shown. ©2012 Morningstar. All Rights Reserved. Unless otherwise provided in a separate agreement, you may use this report only in the country in which its original distributor is based. Data as originally reported. The information contained herein is not represented or warranted to be accurate, correct, complete, or timely. This report is for information purposes only, and should not be considered a solicitation to buy or sell any security. Redistribution is prohibited without written permission. To order reprints, call +1 312-696-6100. To license the research, call +1 312-696-6869.ß ® AspenBio Pharma is a healthcare product development company. The company has products in multiple stages of development dealing with human diagnostic and animal healthcare related issues. These include the company s headliner known as AppyScore, which acts as a test for acute appendicitis. There are also several other drugs being developed and intended for use in animal production. Employees: 361585 South Perry Street Castle Rock, CO 80104 Phone: 1 303 794-2000 Website: http://www.aspenbioinc.com - Morningstar Equity Research |
Navigation | Previous Page / Next Page |
Suggested Link Details/Purchase | |
Following Datasheets | APR_-_RADARCON_2012 (1 pages) APR23 (60 pages) APR40 (108 pages) april07 (16 pages) april_2009 (51 pages) APS3603_Rev_1_1-1 (12 pages) APS3603_Rev_1_1 (12 pages) APS3605_Rev_1_4 (12 pages) APS3606_Rev_0_4 (8 pages) APS3608_Rev_1_0-1 (12 pages) |
Check in e-portals![]() |
World-H-News Products Extensions Partners Automation Jet Parts |
Sitemap Folder | group1 group2 group3 group4 group5 group6 group7 group8 group9 group10 group11 group12 group13 group14 group15 group16 group17 group18 group19 group20 group21 group22 group23 group24 group25 group26 group27 group28 group29 group30 group31 group32 group33 group34 group35 group36 group37 group38 group39 group40 group41 group42 group43 group44 group45 group46 group47 group48 group49 group50 group51 group52 group53 group54 group55 group56 group57 group58 group59 group60 group61 group62 group63 group64 group65 group66 group67 group68 group69 group70 group71 group72 group73 group74 group75 group76 group77 group78 group79 group80 group81 group82 group83 group84 group85 group86 group87 group88 group89 group90 group91 group92 group93 group94 group95 group96 group97 group98 group99 group100 Prewious Folder Next Folder |